glp 1 receptor agonists effects on cardiovascular risk reduction and Tolerability of GLP-1 Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients A Comprehensive Review of the

Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 719.Chaudhri O.B., Parkinson J.R., Kuo Y.T., Druce M.R., Herlihy A.H., Bell J.D

122 Interestingly, GLP-1/estrogen demonstrates a promising role in improving ovarian cyclicity in milder PCOS phenotypes with preserved ovulatory function, effectively normalizing cycle irregularities and enhancing reproductive hormonal balance, while, at lower doses, it outperformed other multi-agonists by reducing body weight (by 10%), fat mass (by 50%), and improving glucose metabolism and insulin sensitivity in PCOS models, without causing significant changes in ovarian or uterine parameters

A structured discontinuation plan should include strategies for maintaining glycemic control and weight management, such as initiating alternative medications, intensifying lifestyle modifications, and scheduling appropriate follow-up appointments

More likely, if you achieve rapid, significant weight loss on these drugs, you might temporarily disrupt the hair growth cycle